Hosted on MSN1d
EBS obtains rights to Hikma's Kloxxado naloxone spray
Kloxxado is a 8mg naloxone nasal spray product used for the emergency treatment of known or suspected opioid overdoses.
Contract Pharma1d
Hikma Partners with Emergent for the Sale of KLOXXADO in the U.S. & Canada
Hikma Pharmaceuticals PLC, the multinational pharmaceutical group, has entered an exclusive commercial partnership with ...
Emergent BioSolutions Gains Exclusive Commercial Rights to KLOXXADO® (naloxone HCI) Nasal Spray from Hikma Pharmaceuticals
Alongside over-the-counter NARCAN® Nasal Spray 4 mg, prescription KLOXXADO® (naloxone HCl) Nasal Spray 8 mg will expand Emergent’s ability to ...
Emergent BioSolutions, Hikma enter partnership for sale of Kloxxado nasal spray
Hikma Pharmaceuticals (HKMPF) announces that it has entered an exclusive commercial partnership with Emergent BioSolutions (EBS) for the sale ...
Las Vegas Sun3d
Alternative remedies prescribed as FDA weighs whether to pull plug on drug
Dr. Scott Manthei of the Nevada Ear and Sinus Institute has been advising patients against taking drugs like Sudafed for ...
Hosted on MSN6d
Allergies: What They Are, Causes, Types, Symptoms, Treatment & Relief
Allergies are a type of hypersensitivity reaction caused by the immune system. There are many types of allergies. You can be ...